Fall Meeting
ANNA 2007 Satellite Symposium
Chronic Kidney Disease - Mineral Bone Disorder

Implications of Mineral Metabolism in End Stage Renal Disease: Role in Cardiovascular Mortality
Jose A.L. Arruda, MD, FACP

Bone and Mineral Management in CKD
Jennifer L. Snavely, CRNP-BC, MSN, CNN

At the conclusion of the certified activity, participants should be able to do the following:
1. Understand how mortality is related to serum levels of calcium, phosphorus, and PTH in observational studies, and also the observational studies that have associated survival with use of vitamin D compounds in dialysis patients.
2. Understand the degree to which vascular calcification progresses in dialysis patients, and how vascular calcification is related to mortality.
3. Understand the studies that have been conducted examining vascular calcification and mortality with use of different phosphate binders.
4. Understand how and when to use vitamin D for the control of serum PTH.

Jose A.L. Arruda, MD, FACP
Keeton Professor of Medicine
University of Illinois at Chicago School of Medicine
Chicago, IL

Jennifer L. Snavely, CRNP-BC, MSN, CNN
Nurse Practicioner
Hypertension and Kidney Specialists
Lancaster, PA

This satellite symposium is sponsored by an unrestricted educational grant from Genzyme Pharmaceuticals, Inc. This activity has been planned and produced in accordance with CE guidelines and policies. From a CE symposium held on October 20-22, 2007 at the American Nephrology Nurses' Association (ANNA) Fall Meeting in San Francisco, CA.

This activity provides 1.25 contact hours.

The American Nephrology Nurses’ Association (ANNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.25 contact hours.

Posting Date: January 15, 2008
CE Credit Eligible Through: January 15, 2010
CE Credit Hours/Completion Time: 1.25
Target Audiences: Nurses, nurse practitioners, and other healthcare professionals who treat and manage patients with CKD.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the linked abstracts in the post-test answer feedback material.
See individual talks.

This ANNA Satellite symposium was developed by ANNA, and sponsored by an unrestricted educational grant from Genzyme, Inc.

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.